Cargando…
Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy
INTRODUCTION: The objective was to estimate, from the perspective of a managed care organization in the United States, the budget impact and effect on health outcomes of expanded use of vagus nerve stimulation [VNS (VNS Therapy(®))] among patients aged ≥ 12 years with drug-resistant epilepsy (DRE) w...
Autores principales: | Purser, Molly F., Mladsi, Deirdre M., Beckman, Alan, Barion, Francesca, Forsey, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182643/ https://www.ncbi.nlm.nih.gov/pubmed/30143957 http://dx.doi.org/10.1007/s12325-018-0775-0 |
Ejemplares similares
-
Correction to: Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy
por: Purser, Molly F., et al.
Publicado: (2018) -
The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization
por: Sangare, Aude, et al.
Publicado: (2020) -
Vagus nerve stimulation in children with drug-resistant epilepsy of monogenic etiology
por: Xie, Han, et al.
Publicado: (2022) -
Research progress of vagus nerve stimulation in the treatment of epilepsy
por: Fan, Jing‐Jing, et al.
Publicado: (2019) -
Factors Affecting Vagus Nerve Stimulation Outcomes in Epilepsy
por: Abbasi, Mehdi, et al.
Publicado: (2021)